Progression from Excessive to Deficient Syndromes in Chronic Hepatitis B: A Dynamical Network Analysis of miRNA Array Data

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">TCM syndromes</td><td align="left">Kegg terms</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">LGDHS/normal</td><td align="left">Glioma; pathways in cancer</td></tr><tr><td align="left">LDSDS/normal</td><td align="left">Pyrimidine metabolism; purine metabolism; RNA polymerase; ubiquitin-mediated proteolysis</td></tr><tr><td align="left">LKYDS/normal</td><td align="left">Pathways in cancer; TGF-beta signaling pathway; colorectal cancer</td></tr><tr><td align="left">LGDHS/LDSDS </td><td align="left">Cell cycle; chronic myeloid leukemia; p53 signaling pathway; pathways in cancer; pancreatic cancer; colorectal cancer; bladder cancer; glioma; prostate cancer; small cell lung cancer; melanoma; nonsmall cell lung cancer; renal cell carcinoma; TGF-beta signaling pathway; ErbB signaling pathway; insulin signaling pathway</td></tr><tr><td align="left">LDSDS/LKYDS</td><td align="left">Cell cycle; colorectal cancer</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

KEGG terms distribution of downregulated genes (upexpression level of miRNAs) of TCM syndromes in CHB.

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: Progression from Excessive to Deficient Syndromes in Chronic Hepatitis B: A Dynamical Network Analysis of miRNA Array Data 